Elevate Capital Advisors LLC Purchases New Shares in Danaher Co. (NYSE:DHR)

Elevate Capital Advisors LLC acquired a new position in shares of Danaher Co. (NYSE:DHR) during the fourth quarter, HoldingsChannel reports. The fund acquired 3,610 shares of the conglomerate’s stock, valued at approximately $829,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Angeles Wealth Management LLC increased its holdings in shares of Danaher by 5.1% in the fourth quarter. Angeles Wealth Management LLC now owns 4,229 shares of the conglomerate’s stock valued at $971,000 after purchasing an additional 204 shares in the last quarter. Newbridge Financial Services Group Inc. acquired a new stake in shares of Danaher in the 4th quarter valued at $193,000. Kestra Private Wealth Services LLC raised its position in shares of Danaher by 11.2% during the fourth quarter. Kestra Private Wealth Services LLC now owns 17,480 shares of the conglomerate’s stock worth $4,013,000 after acquiring an additional 1,754 shares during the last quarter. Howland Capital Management LLC lifted its stake in shares of Danaher by 2.4% during the fourth quarter. Howland Capital Management LLC now owns 189,929 shares of the conglomerate’s stock valued at $43,649,000 after acquiring an additional 4,491 shares during the period. Finally, Entropy Technologies LP boosted its holdings in Danaher by 126.4% in the fourth quarter. Entropy Technologies LP now owns 54,567 shares of the conglomerate’s stock valued at $12,526,000 after acquiring an additional 30,464 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Activity

In related news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 11.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on DHR shares. UBS Group dropped their price objective on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a report on Wednesday, October 23rd. Wolfe Research upgraded shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective on the stock in a report on Thursday, October 31st. Jefferies Financial Group reduced their price target on Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research report on Wednesday, January 29th. TD Cowen upped their price target on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Finally, Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective on the stock in a research note on Friday, December 13th. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $278.00.

Danaher Stock Down 1.5 %

NYSE:DHR opened at $206.92 on Monday. The firm has a market capitalization of $149.45 billion, a price-to-earnings ratio of 39.19, a price-to-earnings-growth ratio of 2.68 and a beta of 0.83. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a twelve month low of $205.79 and a twelve month high of $281.70. The stock’s 50 day moving average price is $232.72 and its two-hundred day moving average price is $251.70.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the firm posted $2.09 earnings per share. Equities research analysts expect that Danaher Co. will post 7.67 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were paid a $0.27 dividend. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.52%. Danaher’s dividend payout ratio is 20.45%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.